IL110013A - Phospholipase inhibitors (ALP) (A22 which are the result of alkenoic and alkadianic acids 4 phenyl) 5 substituted (their preparation and pharmaceutical preparations containing or - Google Patents

Phospholipase inhibitors (ALP) (A22 which are the result of alkenoic and alkadianic acids 4 phenyl) 5 substituted (their preparation and pharmaceutical preparations containing or

Info

Publication number
IL110013A
IL110013A IL11001394A IL11001394A IL110013A IL 110013 A IL110013 A IL 110013A IL 11001394 A IL11001394 A IL 11001394A IL 11001394 A IL11001394 A IL 11001394A IL 110013 A IL110013 A IL 110013A
Authority
IL
Israel
Prior art keywords
arh
mhz
adamantyl
nmr
cdci3
Prior art date
Application number
IL11001394A
Other languages
English (en)
Hebrew (he)
Other versions
IL110013A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/200,798 external-priority patent/US5436369A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL110013A0 publication Critical patent/IL110013A0/xx
Publication of IL110013A publication Critical patent/IL110013A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL11001394A 1993-06-16 1994-06-14 Phospholipase inhibitors (ALP) (A22 which are the result of alkenoic and alkadianic acids 4 phenyl) 5 substituted (their preparation and pharmaceutical preparations containing or IL110013A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7907293A 1993-06-16 1993-06-16
US08/200,798 US5436369A (en) 1993-06-16 1994-02-23 Alicyclic phospholipase A2 inhibitors

Publications (2)

Publication Number Publication Date
IL110013A0 IL110013A0 (en) 1994-10-07
IL110013A true IL110013A (en) 1998-07-15

Family

ID=26761593

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11001394A IL110013A (en) 1993-06-16 1994-06-14 Phospholipase inhibitors (ALP) (A22 which are the result of alkenoic and alkadianic acids 4 phenyl) 5 substituted (their preparation and pharmaceutical preparations containing or

Country Status (22)

Country Link
EP (1) EP0629604B1 (xx)
JP (1) JPH0717913A (xx)
CN (1) CN1099380A (xx)
AT (1) ATE151742T1 (xx)
AU (1) AU667777B2 (xx)
CA (1) CA2125802A1 (xx)
CY (1) CY2020A (xx)
CZ (1) CZ288786B6 (xx)
DE (1) DE69402613T2 (xx)
DK (1) DK0629604T3 (xx)
ES (1) ES2102776T3 (xx)
FI (1) FI942796A (xx)
GR (1) GR3024104T3 (xx)
HK (1) HK116797A (xx)
HU (1) HU222521B1 (xx)
IL (1) IL110013A (xx)
NO (1) NO301417B1 (xx)
NZ (1) NZ260735A (xx)
PL (1) PL176790B1 (xx)
SG (1) SG50539A1 (xx)
TW (1) TW419461B (xx)
ZA (1) ZA944227B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1764405A1 (en) * 2005-09-20 2007-03-21 Rolic AG Functionalized photoreactive compounds
RU2453536C2 (ru) * 2007-10-22 2012-06-20 Оркид Рисерч Лабораториз Лимитед Ингибиторы гистондезацетилазы

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS244440B2 (en) * 1983-02-28 1986-07-17 Celamerck Gmbh & Co Kg Method of acrylic acids' new amides production

Also Published As

Publication number Publication date
SG50539A1 (en) 1998-07-20
CN1099380A (zh) 1995-03-01
IL110013A0 (en) 1994-10-07
HU9401789D0 (en) 1994-09-28
TW419461B (en) 2001-01-21
HUT70550A (en) 1995-10-30
PL176790B1 (pl) 1999-07-30
AU667777B2 (en) 1996-04-04
CZ288786B6 (cs) 2001-09-12
EP0629604A3 (en) 1995-03-01
ES2102776T3 (es) 1997-08-01
PL303862A1 (en) 1994-12-27
NO301417B1 (no) 1997-10-27
JPH0717913A (ja) 1995-01-20
HK116797A (en) 1997-09-05
HU222521B1 (hu) 2003-08-28
CY2020A (en) 1998-02-20
ATE151742T1 (de) 1997-05-15
AU6466694A (en) 1994-12-22
ZA944227B (en) 1995-02-10
EP0629604B1 (en) 1997-04-16
NZ260735A (en) 1996-12-20
NO942244D0 (no) 1994-06-15
DK0629604T3 (da) 1997-09-15
EP0629604A2 (en) 1994-12-21
NO942244L (no) 1994-12-19
FI942796A0 (fi) 1994-06-13
CA2125802A1 (en) 1994-12-17
FI942796A (fi) 1994-12-17
CZ147294A3 (en) 1995-01-18
GR3024104T3 (en) 1997-10-31
DE69402613T2 (de) 1997-10-30
DE69402613D1 (de) 1997-05-22

Similar Documents

Publication Publication Date Title
HU225939B1 (en) Substituted 4-biarylbutyric or 5-biarylentanoic acid derivatives as matrix metalloprotease inhibitiors, preparation thereof and pharmaceutical compositions containing these compounds
JP4072208B2 (ja) レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体
FI108642B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi
JPH08291094A (ja) 限定された９−シス−レチノイド
JPH07504169A (ja) レチノイド様生物学的活性を有する置換フェニルエテニル化合物
AU2008205312A1 (en) Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
AU640777B2 (en) Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
EP0466198A1 (en) A lipoxygenase inhibitor
US5872118A (en) Bicyclic amide derivatives and their use as muscle relaxants
EP0664282B1 (en) Biaryl phospholipase A2 inhibitors
FR2612924A1 (fr) Derives de tetrazole antihypercholesterolemiques
US5436369A (en) Alicyclic phospholipase A2 inhibitors
HU196365B (en) Process for production of derivatives of leucotriene antagonistic carbon acid and medical preparatives containing such compositions
IL110013A (en) Phospholipase inhibitors (ALP) (A22 which are the result of alkenoic and alkadianic acids 4 phenyl) 5 substituted (their preparation and pharmaceutical preparations containing or
CA2980221C (en) Indole analogs as 5-oxo-ete receptor antagonists and method of use thereof
Bronson et al. Alicyclic phospholipase A 2 inhibitors
JPH043377B2 (xx)
US5434288A (en) PLA2 inhibitors
US5183942A (en) Ten-membered ring enediynediols and enediynediones having DNA cleaving properties
US3803203A (en) Alpha-(4-cyano-4-aryl-1-cyclohexenyl)-propionic acids and esters
CA2277042A1 (fr) Composes tetracycliques aromatiques de type retinoide, leur procede de preparation et leur utilisation
Springer et al. Biaryl phospholipase A 2 inhibitors

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees